0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Equine Pharmaceuticals and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-34V6752
Home | Market Reports | Pets & Animals| Animal Products & Services| Pet Food & Supplies
China Equine Pharmaceuticals and Supplements Market Report Forecast 2021 2027
BUY CHAPTERS

Equine Pharmaceuticals and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34V6752
Report
April 2024
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Equine Pharmaceuticals and Supplements - Market Size

The global market for Equine Pharmaceuticals and Supplements was estimated to be worth US$ 1148 million in 2023 and is forecast to a readjusted size of US$ 1568 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Equine Pharmaceuticals and Supplements - Market

Equine Pharmaceuticals and Supplements - Market

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Equine Pharmaceuticals and Supplements, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Equine Pharmaceuticals and Supplements by region & country, by Type, and by Application.
The Equine Pharmaceuticals and Supplements market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Pharmaceuticals and Supplements.
Market Segmentation

Scope of Equine Pharmaceuticals and Supplements - Market Report

Report Metric Details
Report Name Equine Pharmaceuticals and Supplements - Market
Forecasted market size in 2030 US$ 1568 million
CAGR 4.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Pharmaceuticals
  • Supplements
Segment by Application
  • Thoroughbred Horse
  • Other Types of Horses
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Equine Pharmaceuticals and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Equine Pharmaceuticals and Supplements in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Equine Pharmaceuticals and Supplements - Market size in 2030?

Ans: The Equine Pharmaceuticals and Supplements - Market size in 2030 will be US$ 1568 million.

What is the market share of major companies in Equine Pharmaceuticals and Supplements - Market?

Ans: Global top three manufacturers hold a share over 50%.

What is the Equine Pharmaceuticals and Supplements - Market share by type?

Ans: In terms of product, Pharmaceuticals is the largest segment, with a share about 80%.

Who are the main players in the Equine Pharmaceuticals and Supplements - Market report?

Ans: The main players in the Equine Pharmaceuticals and Supplements - Market are Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude

What are the Application segmentation covered in the Equine Pharmaceuticals and Supplements - Market report?

Ans: The Applications covered in the Equine Pharmaceuticals and Supplements - Market report are Thoroughbred Horse, Other Types of Horses

What are the Type segmentation covered in the Equine Pharmaceuticals and Supplements - Market report?

Ans: The Types covered in the Equine Pharmaceuticals and Supplements - Market report are Pharmaceuticals, Supplements

1 Market Overview
1.1 Equine Pharmaceuticals and Supplements Product Introduction
1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast
1.2.1 Global Equine Pharmaceuticals and Supplements Sales Value (2019-2030)
1.2.2 Global Equine Pharmaceuticals and Supplements Sales Volume (2019-2030)
1.2.3 Global Equine Pharmaceuticals and Supplements Sales Price (2019-2030)
1.3 Equine Pharmaceuticals and Supplements Market Trends & Drivers
1.3.1 Equine Pharmaceuticals and Supplements Industry Trends
1.3.2 Equine Pharmaceuticals and Supplements Market Drivers & Opportunity
1.3.3 Equine Pharmaceuticals and Supplements Market Challenges
1.3.4 Equine Pharmaceuticals and Supplements Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Equine Pharmaceuticals and Supplements Players Revenue Ranking (2023)
2.2 Global Equine Pharmaceuticals and Supplements Revenue by Company (2019-2024)
2.3 Global Equine Pharmaceuticals and Supplements Players Sales Volume Ranking (2023)
2.4 Global Equine Pharmaceuticals and Supplements Sales Volume by Company Players (2019-2024)
2.5 Global Equine Pharmaceuticals and Supplements Average Price by Company (2019-2024)
2.6 Key Manufacturers Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Equine Pharmaceuticals and Supplements Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Equine Pharmaceuticals and Supplements
2.9 Equine Pharmaceuticals and Supplements Market Competitive Analysis
2.9.1 Equine Pharmaceuticals and Supplements Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Equine Pharmaceuticals and Supplements Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pharmaceuticals
3.1.2 Supplements
3.2 Global Equine Pharmaceuticals and Supplements Sales Value by Type
3.2.1 Global Equine Pharmaceuticals and Supplements Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Equine Pharmaceuticals and Supplements Sales Value, by Type (2019-2030)
3.2.3 Global Equine Pharmaceuticals and Supplements Sales Value, by Type (%) (2019-2030)
3.3 Global Equine Pharmaceuticals and Supplements Sales Volume by Type
3.3.1 Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Equine Pharmaceuticals and Supplements Sales Volume, by Type (2019-2030)
3.3.3 Global Equine Pharmaceuticals and Supplements Sales Volume, by Type (%) (2019-2030)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Thoroughbred Horse
4.1.2 Other Types of Horses
4.2 Global Equine Pharmaceuticals and Supplements Sales Value by Application
4.2.1 Global Equine Pharmaceuticals and Supplements Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Equine Pharmaceuticals and Supplements Sales Value, by Application (2019-2030)
4.2.3 Global Equine Pharmaceuticals and Supplements Sales Value, by Application (%) (2019-2030)
4.3 Global Equine Pharmaceuticals and Supplements Sales Volume by Application
4.3.1 Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Equine Pharmaceuticals and Supplements Sales Volume, by Application (2019-2030)
4.3.3 Global Equine Pharmaceuticals and Supplements Sales Volume, by Application (%) (2019-2030)
4.4 Global Equine Pharmaceuticals and Supplements Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Equine Pharmaceuticals and Supplements Sales Value by Region
5.1.1 Global Equine Pharmaceuticals and Supplements Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Equine Pharmaceuticals and Supplements Sales Value by Region (2019-2024)
5.1.3 Global Equine Pharmaceuticals and Supplements Sales Value by Region (2025-2030)
5.1.4 Global Equine Pharmaceuticals and Supplements Sales Value by Region (%), (2019-2030)
5.2 Global Equine Pharmaceuticals and Supplements Sales Volume by Region
5.2.1 Global Equine Pharmaceuticals and Supplements Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Equine Pharmaceuticals and Supplements Sales Volume by Region (2019-2024)
5.2.3 Global Equine Pharmaceuticals and Supplements Sales Volume by Region (2025-2030)
5.2.4 Global Equine Pharmaceuticals and Supplements Sales Volume by Region (%), (2019-2030)
5.3 Global Equine Pharmaceuticals and Supplements Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
5.4.2 North America Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
5.5.2 Europe Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
5.6.2 Asia Pacific Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
5.7.2 South America Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
5.8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Value
6.2.1 Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.2.2 Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.3.2 United States Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Equine Pharmaceuticals and Supplements Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.4.2 Europe Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Equine Pharmaceuticals and Supplements Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.5.2 China Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
6.5.3 China Equine Pharmaceuticals and Supplements Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.6.2 Japan Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Equine Pharmaceuticals and Supplements Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.7.2 South Korea Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Equine Pharmaceuticals and Supplements Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.8.2 Southeast Asia Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Equine Pharmaceuticals and Supplements Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Equine Pharmaceuticals and Supplements Sales Value, 2019-2030
6.9.2 India Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
6.9.3 India Equine Pharmaceuticals and Supplements Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Information
7.1.2 Boehringer Ingelheim Introduction and Business Overview
7.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Offerings
7.1.5 Boehringer Ingelheim Recent Development
7.2 Merck Animal Health
7.2.1 Merck Animal Health Company Information
7.2.2 Merck Animal Health Introduction and Business Overview
7.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Offerings
7.2.5 Merck Animal Health Recent Development
7.3 Zoetis
7.3.1 Zoetis Company Information
7.3.2 Zoetis Introduction and Business Overview
7.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Offerings
7.3.5 Zoetis Recent Development
7.4 Bayer Animal Health
7.4.1 Bayer Animal Health Company Information
7.4.2 Bayer Animal Health Introduction and Business Overview
7.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Offerings
7.4.5 Bayer Animal Health Recent Development
7.5 Elanco Animal Health
7.5.1 Elanco Animal Health Company Information
7.5.2 Elanco Animal Health Introduction and Business Overview
7.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Offerings
7.5.5 Elanco Animal Health Recent Development
7.6 Dechra Veterinary Products
7.6.1 Dechra Veterinary Products Company Information
7.6.2 Dechra Veterinary Products Introduction and Business Overview
7.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Offerings
7.6.5 Dechra Veterinary Products Recent Development
7.7 CEVA
7.7.1 CEVA Company Information
7.7.2 CEVA Introduction and Business Overview
7.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.7.4 CEVA Equine Pharmaceuticals and Supplements Product Offerings
7.7.5 CEVA Recent Development
7.8 Virbac
7.8.1 Virbac Company Information
7.8.2 Virbac Introduction and Business Overview
7.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Virbac Equine Pharmaceuticals and Supplements Product Offerings
7.8.5 Virbac Recent Development
7.9 Norbrook Equine
7.9.1 Norbrook Equine Company Information
7.9.2 Norbrook Equine Introduction and Business Overview
7.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Offerings
7.9.5 Norbrook Equine Recent Development
7.10 Kyoritsu Seiyaku
7.10.1 Kyoritsu Seiyaku Company Information
7.10.2 Kyoritsu Seiyaku Introduction and Business Overview
7.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Offerings
7.10.5 Kyoritsu Seiyaku Recent Development
7.11 Vetoquinol
7.11.1 Vetoquinol Company Information
7.11.2 Vetoquinol Introduction and Business Overview
7.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Offerings
7.11.5 Vetoquinol Recent Development
7.12 Protexin Healthcare
7.12.1 Protexin Healthcare Company Information
7.12.2 Protexin Healthcare Introduction and Business Overview
7.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Offerings
7.12.5 Protexin Healthcare Recent Development
7.13 Audevard
7.13.1 Audevard Company Information
7.13.2 Audevard Introduction and Business Overview
7.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Audevard Equine Pharmaceuticals and Supplements Product Offerings
7.13.5 Audevard Recent Development
7.14 Ouro Fino Saude
7.14.1 Ouro Fino Saude Company Information
7.14.2 Ouro Fino Saude Introduction and Business Overview
7.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Offerings
7.14.5 Ouro Fino Saude Recent Development
8 Industry Chain Analysis
8.1 Equine Pharmaceuticals and Supplements Industrial Chain
8.2 Equine Pharmaceuticals and Supplements Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Equine Pharmaceuticals and Supplements Sales Model
8.5.2 Sales Channel
8.5.3 Equine Pharmaceuticals and Supplements Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Equine Pharmaceuticals and Supplements Market Trends
    Table 2. Equine Pharmaceuticals and Supplements Market Drivers & Opportunity
    Table 3. Equine Pharmaceuticals and Supplements Market Challenges
    Table 4. Equine Pharmaceuticals and Supplements Market Restraints
    Table 5. Global Equine Pharmaceuticals and Supplements Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2019-2024)
    Table 7. Global Equine Pharmaceuticals and Supplements Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Equine Pharmaceuticals and Supplements Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Equine Pharmaceuticals and Supplements Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Equine Pharmaceuticals and Supplements Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Equine Pharmaceuticals and Supplements
    Table 13. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Equine Pharmaceuticals and Supplements Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Equine Pharmaceuticals and Supplements Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Equine Pharmaceuticals and Supplements Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Equine Pharmaceuticals and Supplements Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Equine Pharmaceuticals and Supplements Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Equine Pharmaceuticals and Supplements Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Equine Pharmaceuticals and Supplements Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Equine Pharmaceuticals and Supplements Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Equine Pharmaceuticals and Supplements Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Equine Pharmaceuticals and Supplements Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Equine Pharmaceuticals and Supplements Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Equine Pharmaceuticals and Supplements Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Equine Pharmaceuticals and Supplements Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Equine Pharmaceuticals and Supplements Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Equine Pharmaceuticals and Supplements Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Equine Pharmaceuticals and Supplements Sales Value by Region (2019-2024) & (%)
    Table 44. Global Equine Pharmaceuticals and Supplements Sales Value by Region (2025-2030) & (%)
    Table 45. Global Equine Pharmaceuticals and Supplements Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Equine Pharmaceuticals and Supplements Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Equine Pharmaceuticals and Supplements Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Equine Pharmaceuticals and Supplements Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Equine Pharmaceuticals and Supplements Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Equine Pharmaceuticals and Supplements Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Equine Pharmaceuticals and Supplements Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Volume, (2025-2030) & (K Units)
    Table 57. Boehringer Ingelheim Company Information
    Table 58. Boehringer Ingelheim Introduction and Business Overview
    Table 59. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Offerings
    Table 61. Boehringer Ingelheim Recent Development
    Table 62. Merck Animal Health Company Information
    Table 63. Merck Animal Health Introduction and Business Overview
    Table 64. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Merck Animal Health Equine Pharmaceuticals and Supplements Product Offerings
    Table 66. Merck Animal Health Recent Development
    Table 67. Zoetis Company Information
    Table 68. Zoetis Introduction and Business Overview
    Table 69. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Zoetis Equine Pharmaceuticals and Supplements Product Offerings
    Table 71. Zoetis Recent Development
    Table 72. Bayer Animal Health Company Information
    Table 73. Bayer Animal Health Introduction and Business Overview
    Table 74. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Offerings
    Table 76. Bayer Animal Health Recent Development
    Table 77. Elanco Animal Health Company Information
    Table 78. Elanco Animal Health Introduction and Business Overview
    Table 79. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Offerings
    Table 81. Elanco Animal Health Recent Development
    Table 82. Dechra Veterinary Products Company Information
    Table 83. Dechra Veterinary Products Introduction and Business Overview
    Table 84. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Offerings
    Table 86. Dechra Veterinary Products Recent Development
    Table 87. CEVA Company Information
    Table 88. CEVA Introduction and Business Overview
    Table 89. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. CEVA Equine Pharmaceuticals and Supplements Product Offerings
    Table 91. CEVA Recent Development
    Table 92. Virbac Company Information
    Table 93. Virbac Introduction and Business Overview
    Table 94. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Virbac Equine Pharmaceuticals and Supplements Product Offerings
    Table 96. Virbac Recent Development
    Table 97. Norbrook Equine Company Information
    Table 98. Norbrook Equine Introduction and Business Overview
    Table 99. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Norbrook Equine Equine Pharmaceuticals and Supplements Product Offerings
    Table 101. Norbrook Equine Recent Development
    Table 102. Kyoritsu Seiyaku Company Information
    Table 103. Kyoritsu Seiyaku Introduction and Business Overview
    Table 104. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Offerings
    Table 106. Kyoritsu Seiyaku Recent Development
    Table 107. Vetoquinol Company Information
    Table 108. Vetoquinol Introduction and Business Overview
    Table 109. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Vetoquinol Equine Pharmaceuticals and Supplements Product Offerings
    Table 111. Vetoquinol Recent Development
    Table 112. Protexin Healthcare Company Information
    Table 113. Protexin Healthcare Introduction and Business Overview
    Table 114. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Offerings
    Table 116. Protexin Healthcare Recent Development
    Table 117. Audevard Company Information
    Table 118. Audevard Introduction and Business Overview
    Table 119. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Audevard Equine Pharmaceuticals and Supplements Product Offerings
    Table 121. Audevard Recent Development
    Table 122. Ouro Fino Saude Company Information
    Table 123. Ouro Fino Saude Introduction and Business Overview
    Table 124. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Offerings
    Table 126. Ouro Fino Saude Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Equine Pharmaceuticals and Supplements Downstream Customers
    Table 130. Equine Pharmaceuticals and Supplements Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Equine Pharmaceuticals and Supplements Product Picture
    Figure 2. Global Equine Pharmaceuticals and Supplements Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Equine Pharmaceuticals and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Equine Pharmaceuticals and Supplements Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Equine Pharmaceuticals and Supplements Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Equine Pharmaceuticals and Supplements Report Years Considered
    Figure 7. Global Equine Pharmaceuticals and Supplements Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Equine Pharmaceuticals and Supplements Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Equine Pharmaceuticals and Supplements Revenue in 2023
    Figure 10. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Pharmaceuticals Picture
    Figure 12. Supplements Picture
    Figure 13. Global Equine Pharmaceuticals and Supplements Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Equine Pharmaceuticals and Supplements Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Equine Pharmaceuticals and Supplements Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Equine Pharmaceuticals and Supplements Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Thoroughbred Horse
    Figure 19. Product Picture of Other Types of Horses
    Figure 20. Global Equine Pharmaceuticals and Supplements Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Equine Pharmaceuticals and Supplements Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Equine Pharmaceuticals and Supplements Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Equine Pharmaceuticals and Supplements Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Equine Pharmaceuticals and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Equine Pharmaceuticals and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Equine Pharmaceuticals and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Equine Pharmaceuticals and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Equine Pharmaceuticals and Supplements Sales Volume (%), (2019-2030)
    Figure 37. United States Equine Pharmaceuticals and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Equine Pharmaceuticals and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Equine Pharmaceuticals and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Equine Pharmaceuticals and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Equine Pharmaceuticals and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Equine Pharmaceuticals and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Equine Pharmaceuticals and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Equine Pharmaceuticals and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Equine Pharmaceuticals and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Equine Pharmaceuticals and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Equine Pharmaceuticals and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Equine Pharmaceuticals and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Equine Pharmaceuticals and Supplements Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Equine Pharmaceuticals and Supplements Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Equine Pharmaceuticals and Supplements Sales Value by Application (%), 2023 VS 2030
    Figure 58. Equine Pharmaceuticals and Supplements Industrial Chain
    Figure 59. Equine Pharmaceuticals and Supplements Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS